Development and Validation of the Stability-Indicating RP-HPLC Method to Estimate Olaparib in Graphene Quantum Dot Nanoformulation Using Analytical Quality by Design (AQbD) Principles
Indian Journal of Pharmaceutical Education and Research · 05.01.2026 · 60 (2) · 861-868
DOI: 10.5530/ijper.20261817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmaceutical Education and Research, online erschienen am 05.01.2026. Verfasst von Pooja Rayanade und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rayanade, P., Patil, A., Gaude, Y., Salokhe, A., & Shetti, P. (2026). Development and Validation of the Stability-Indicating RP-HPLC Method to Estimate Olaparib in Graphene Quantum Dot Nanoformulation Using Analytical Quality by Design (AQbD) Principles. Indian Journal of Pharmaceutical Education and Research, 60(2), 861-868. https://doi.org/10.5530/ijper.20261817
Vancouver
Rayanade P, Patil A, Gaude Y, Salokhe A, Shetti P. Development and Validation of the Stability-Indicating RP-HPLC Method to Estimate Olaparib in Graphene Quantum Dot Nanoformulation Using Analytical Quality by Design (AQbD) Principles. Indian Journal of Pharmaceutical Education and Research. 2026;60(2):861-868. doi:10.5530/ijper.20261817
BibTeX
@article{Rayanade2026,
author = {Rayanade, Pooja and Patil, Archana and Gaude, Yadishma and Salokhe, Abhijit and Shetti, Priya},
title = {Development and Validation of the Stability-Indicating RP-HPLC Method to Estimate Olaparib in Graphene Quantum Dot Nanoformulation Using Analytical Quality by Design (AQbD) Principles},
journal = {Indian Journal of Pharmaceutical Education and Research},
year = {2026},
volume = {60},
number = {2},
pages = {861--868},
doi = {10.5530/ijper.20261817}
}
EUVIMED